Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Private equity deal count in healthcare services was down nearly 19% in the second quarter of 2026 compared to the same time last year, PitchBook finds. | Three of four segments, except ancillary and outsourced services, face weakness amid macroeconomic headwinds like looming interest rate hikes and low healthcare services utilization.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

Elevated medical costs and policy turmoil continued to affect the financial performance of payers and providers in the second…

The number of insurers offering plans on the Affordable Care Act's marketplaces declined between 2025 and 2026, with more payers…

Enrollment in Affordable Care Act marketplace plans could decline to 17.5 million people this year, according to a new KFF…

Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement…

The tempo of healthcare bankruptcy filings during the front half of 2026 has increased slightly compared to last year, but the…